SGRX(SGRX)
SGRX
10/7/26
Sangrix (SGRX)
Wednesday
12:32 PM
ThesisOperational losses and increased competition have led to a more cautious outlook among investors, despite potential growth opportunities.
Revenue Outlook
What Moves the Stock
- 01Regulatory approvals for new biopesticide products
- 02Fluctuations in commodity prices affecting farmer spending
- 03Adoption rates of sustainable farming practices
- 04Partnerships with large agricultural firms
- 05Biopesticides - 60%
- 06Fertilizers - 30%
- 07Consulting services - 10%
- 08Sustainable agriculture practices
FY2025 Snapshot
- Revenue
- $39.5K
- Rev. Growth
- -98.6%
- Gross Margin
- 0.0%
- Op. Margin
- -7575%
- Net Margin
- -11108%
- Net Income
- $-4M
- NI Growth
- +75.0%
- EPS
- $-84.85
- 1Y Return
- -99.5%
SGRX Chart
My Notes
- "Management noted, 'While we see growth potential, current market pressures are challenging our profitability.'"
- Moat: Sangrix's competitive advantage lies in its proprietary technology and focus on sustainability…
- growth - Investors looking for exposure to sustainable agriculture and innovation.
- Higher interest rates may increase financing costs for farmers, potentially reducing their spending on crop inputs…
- Watch on earnings: Corn and soybean prices (ZCUSX, ZSUSX), Regulatory approval timelines for new products, R&D spending trends.
One Sentence Summary:
Sangrix: the story is balanced — regulatory approvals for new biopesticide products.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers
